As of 2024-12-14, the Relative Valuation of TG Therapeutics Inc (TGTX) is (0.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.02 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -100.2%.
The range of the Relative Valuation is (1.60) - 3.20 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 34.4x | 25.8x |
| Forward P/E multiples | 19.4x - 47.1x | 33.2x |
| Fair Price | (1.60) - 3.20 | (0.06) |
| Upside | -105.0% - -90.0% | -100.2% |
| Date | P/E |
| 2024-12-13 | -347.02 |
| 2024-12-12 | -332.60 |
| 2024-12-11 | -343.01 |
| 2024-12-10 | -343.22 |
| 2024-12-09 | -355.90 |
| 2024-12-06 | -367.72 |
| 2024-12-05 | -364.68 |
| 2024-12-04 | -367.17 |
| 2024-12-03 | -361.86 |
| 2024-12-02 | -380.29 |
| 2024-11-29 | -377.15 |
| 2024-11-27 | -379.31 |
| 2024-11-26 | -371.29 |
| 2024-11-25 | -375.09 |
| 2024-11-22 | -380.07 |
| 2024-11-21 | -374.44 |
| 2024-11-20 | -337.59 |
| 2024-11-19 | -328.59 |
| 2024-11-18 | -320.90 |
| 2024-11-15 | -320.14 |
| 2024-11-14 | -334.28 |
| 2024-11-13 | -378.23 |
| 2024-11-12 | -334.99 |
| 2024-11-11 | -333.15 |
| 2024-11-08 | -312.23 |
| 2024-11-07 | -302.37 |
| 2024-11-06 | -294.46 |
| 2024-11-05 | -280.26 |
| 2024-11-04 | -264.00 |
| 2024-11-01 | -291.53 |
| 2024-10-31 | -271.59 |
| 2024-10-30 | -272.35 |
| 2024-10-29 | -278.63 |
| 2024-10-28 | -263.89 |
| 2024-10-25 | -253.16 |
| 2024-10-24 | -251.65 |
| 2024-10-23 | -250.67 |
| 2024-10-22 | -262.81 |
| 2024-10-21 | -264.11 |
| 2024-10-18 | -252.62 |
| 2024-10-17 | -259.45 |
| 2024-10-16 | -265.52 |
| 2024-10-15 | -266.28 |
| 2024-10-14 | -247.42 |
| 2024-10-11 | -240.38 |
| 2024-10-10 | -236.58 |
| 2024-10-09 | -237.29 |
| 2024-10-08 | -236.69 |
| 2024-10-07 | -230.95 |
| 2024-10-04 | -240.92 |